xenoport

  1. T

    GlaxoSmithKline And XenoPort Receive FDA Complete Response Letter For Horizant™ (GSK1

    GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™(gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic...
    • tD33NAt
    • Thread
    • complete fda glaxosmithkline gsk1 letter receive response xenoport
    • Replies: 0
    • Forum: Health and Fitness
  2. T

    GlaxoSmithKline And XenoPort Receive FDA Complete Response Letter For Horizant™ (GSK1

    GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™(gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic...
    • tD33NAt
    • Thread
    • complete fda glaxosmithkline gsk1 letter receive response xenoport
    • Replies: 0
    • Forum: Health and Fitness
  3. T

    GlaxoSmithKline And XenoPort Receive FDA Complete Response Letter For Horizant™ (GSK1

    GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™(gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic...
    • tD33NAt
    • Thread
    • complete fda glaxosmithkline gsk1 horizantâ„¢ letter receive response xenoport
    • Replies: 0
    • Forum: Health and Fitness
Top